SCHEMBL29832209

SCHEMBL29832209

O=C(Nc1ncnc2c1ncn2[C@@H]1O[C@H](CI)[C@@H](O)[C@H]1F)c1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RY12 Q9H244 2/20 0.52
▸ BMPR1B O00238 1/20 0.51
▸ ADORA1 P30542 4/20 0.50
▸ LMNA P02545 2/20 0.50
▸ SLC29A1 Q99808 2/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ GLA P06280 1/20 0.50
▸ PMP22 Q01453 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ NPY1R P25929 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ NPY2R P49146 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ RXFP1 Q9HBX9 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ NFKB1 P19838 1/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19127970 1.00 P2RY12 (0.52) P2RY12BMPR1BADORA1LMNASLC29A1
SCHEMBL28428736 0.94 P2RY12 (0.53) P2RY12BMPR1BADORA1LMNASLC29A1
SCHEMBL31725279 0.93 LMNA (0.54) P2RY12BMPR1BADORA1LMNASLC29A1
SCHEMBL18521420 0.92 LMNA (0.60) ADORA1LMNASLC29A1ALDH1A1GLA
SCHEMBL21625242 0.92 LMNA (0.60) ADORA1LMNASLC29A1ALDH1A1GLA
SCHEMBL23621389 0.92 LMNA (0.60) ADORA1LMNASLC29A1ALDH1A1GLA
SCHEMBL314050 0.92 LMNA (0.60) ADORA1LMNASLC29A1ALDH1A1GLA
SCHEMBL21063207 0.92 LMNA (0.60) ADORA1LMNASLC29A1ALDH1A1GLA
SCHEMBL9294393 0.92 LMNA (0.60) ADORA1LMNASLC29A1ALDH1A1GLA
SCHEMBL314052 0.92 LMNA (0.60) ADORA1LMNASLC29A1ALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109451740-B Cyclic dinucleotides for the treatment of disorders associated with STING activity, such as cancer 先天肿瘤免疫公司 2022-09-02 — — CN disclosed
Send feedback